310 related articles for article (PubMed ID: 32755162)
1. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
2. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
[No Abstract] [Full Text] [Related]
3. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
[TBL] [Abstract][Full Text] [Related]
5. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
[TBL] [Abstract][Full Text] [Related]
6. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
7. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
Ko KH; Jung HK; Kim I
Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
[TBL] [Abstract][Full Text] [Related]
9. Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the DENSE trial.
Wang H; H M van der Velden B; Verburg E; Bakker MF; Pijnappel RM; Veldhuis WB; van Gils CH; Gilhuijs KGA
Eur J Radiol; 2024 Jun; 175():111442. PubMed ID: 38583349
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
12. Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.
Zhao S; Zhang X; Zhong H; Qin Y; Li Y; Song B; Huang J; Yu J
Sci Rep; 2020 May; 10(1):8608. PubMed ID: 32451404
[TBL] [Abstract][Full Text] [Related]
13. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
[TBL] [Abstract][Full Text] [Related]
14. Deep-learning model for background parenchymal enhancement classification in contrast-enhanced mammography.
Ripaud E; Jailin C; Quintana GI; Milioni de Carvalho P; Sanchez de la Rosa R; Vancamberg L
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38657641
[No Abstract] [Full Text] [Related]
15. Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
Grimm LJ; Saha A; Ghate SV; Kim C; Soo MS; Yoon SC; Mazurowski MA
Acad Radiol; 2019 Jan; 26(1):69-75. PubMed ID: 29602724
[TBL] [Abstract][Full Text] [Related]
16. Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging.
Kawamura A; Satake H; Ishigaki S; Ikeda M; Kimura R; Shimamoto K; Naganawa S
Nagoya J Med Sci; 2015 Aug; 77(3):425-37. PubMed ID: 26412889
[TBL] [Abstract][Full Text] [Related]
17. MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.
Lo Gullo R; Daimiel I; Rossi Saccarelli C; Bitencourt A; Sevilimedu V; Martinez DF; Jochelson MS; Morris EA; Reiner JS; Pinker K
Breast Cancer Res; 2020 Aug; 22(1):93. PubMed ID: 32819432
[TBL] [Abstract][Full Text] [Related]
18. Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.
Xu C; Jiang M; Lin F; Zhang K; Xie H; Lv W; Ji H; Mao N
Br J Radiol; 2023 Aug; 96(1148):20220051. PubMed ID: 37227804
[TBL] [Abstract][Full Text] [Related]
19. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
